Medpace (MEDP) Competitors $337.28 +2.13 (+0.64%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MEDP vs. IQV, RDDT, CPAY, GIB, KSPI, GRAB, TRU, AER, Z, and TOSTShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include IQVIA (IQV), Reddit (RDDT), Corpay (CPAY), CGI (GIB), Joint Stock Company Kaspi.kz (KSPI), Grab (GRAB), TransUnion (TRU), AerCap (AER), Zillow Group (Z), and Toast (TOST). These companies are all part of the "business services" industry. Medpace vs. IQVIA Reddit Corpay CGI Joint Stock Company Kaspi.kz Grab TransUnion AerCap Zillow Group Toast IQVIA (NYSE:IQV) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation, community ranking and earnings. Does the media favor IQV or MEDP? In the previous week, IQVIA had 10 more articles in the media than Medpace. MarketBeat recorded 19 mentions for IQVIA and 9 mentions for Medpace. Medpace's average media sentiment score of 0.84 beat IQVIA's score of 0.70 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IQVIA 4 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Medpace 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend IQV or MEDP? IQVIA currently has a consensus price target of $255.82, suggesting a potential upside of 29.68%. Medpace has a consensus price target of $380.56, suggesting a potential upside of 12.83%. Given IQVIA's stronger consensus rating and higher probable upside, equities research analysts plainly believe IQVIA is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQVIA 0 Sell rating(s) 3 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 2.90Medpace 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 Which has preferable earnings & valuation, IQV or MEDP? IQVIA has higher revenue and earnings than Medpace. IQVIA is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQVIA$15.32B2.34$1.36B$7.6225.89Medpace$2.07B5.06$282.81M$11.4229.53 Does the MarketBeat Community prefer IQV or MEDP? IQVIA received 321 more outperform votes than Medpace when rated by MarketBeat users. Likewise, 68.32% of users gave IQVIA an outperform vote while only 63.65% of users gave Medpace an outperform vote. CompanyUnderperformOutperformIQVIAOutperform Votes67368.32% Underperform Votes31231.68% MedpaceOutperform Votes35263.65% Underperform Votes20136.35% Which has more risk and volatility, IQV or MEDP? IQVIA has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Do insiders & institutionals have more ownership in IQV or MEDP? 89.6% of IQVIA shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 1.6% of IQVIA shares are held by company insiders. Comparatively, 20.3% of Medpace shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is IQV or MEDP more profitable? Medpace has a net margin of 17.66% compared to IQVIA's net margin of 9.17%. Medpace's return on equity of 50.87% beat IQVIA's return on equity.Company Net Margins Return on Equity Return on Assets IQVIA9.17% 28.17% 6.89% Medpace 17.66%50.87%19.61% SummaryIQVIA beats Medpace on 11 of the 19 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.48B$4.20B$5.10B$9.08BDividend YieldN/A1.78%4.88%4.21%P/E Ratio29.5355.3490.8317.14Price / Sales5.0649.001,112.01116.85Price / Cash33.9023.6242.0237.88Price / Book18.513.144.774.78Net Income$282.81M$139.50M$119.70M$225.60M7 Day Performance-2.50%-2.28%-1.86%-1.23%1 Month Performance-1.34%1.05%11.45%3.07%1 Year Performance9.01%12.00%30.43%16.48% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.6869 of 5 stars$337.28+0.6%$380.56+12.8%+11.3%$10.48B$2.07B29.535,900High Trading VolumeIQVIQVIA4.9233 of 5 stars$197.61-0.7%$256.19+29.6%-12.3%$35.87B$14.98B26.1287,000Analyst ForecastRDDTReddit1.1771 of 5 stars$178.34+3.3%$124.42-30.2%N/A$31.31B$1.12B0.002,013Analyst ForecastInsider TradeCPAYCorpay3.4371 of 5 stars$361.14+1.1%$369.29+2.3%N/A$25.18B$3.88B25.5910,500Positive NewsGIBCGI3.8085 of 5 stars$110.42-1.9%$137.00+24.1%+2.9%$25.17B$14.52B20.9391,500Positive NewsKSPIJoint Stock Company Kaspi.kz3.9241 of 5 stars$105.07-0.9%$147.20+40.1%N/A$20.96B$2.36T0.008,772News CoverageGRABGrab1.8278 of 5 stars$5.18+1.0%$5.53+6.7%+54.6%$20.86B$2.69B-256.509,490TRUTransUnion4.8171 of 5 stars$99.17+0.8%$107.06+8.0%+43.9%$19.33B$4.10B86.2013,200Positive NewsAERAerCap3.3331 of 5 stars$97.45+1.9%$112.00+14.9%+31.5%$19.29B$7.58B7.58740Positive NewsZZillow Group1.5994 of 5 stars$81.05+1.4%$70.33-13.2%+35.6%$18.93B$1.95B-140.235,720TOSTToast1.9811 of 5 stars$38.74+1.6%$34.81-10.1%+109.2%$18.25B$3.87B-293.315,500Insider Trade Related Companies and Tools Related Companies IQVIA Alternatives Reddit Alternatives Corpay Alternatives CGI Alternatives Joint Stock Company Kaspi.kz Alternatives Grab Alternatives TransUnion Alternatives AerCap Alternatives Zillow Group Alternatives Toast Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MEDP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
